+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
From
Hemophilia Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Hemophilia Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 143 Pages
  • Global
From
Injection Pen Market 2024-2028 - Product Thumbnail Image

Injection Pen Market 2024-2028

  • Report
  • October 2023
  • 172 Pages
  • Global
From
From
From
From
Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
From
From
From
Pharmaceutical Market in Denmark 2025-2029 - Product Thumbnail Image

Pharmaceutical Market in Denmark 2025-2029

  • Report
  • March 2025
  • 186 Pages
  • Denmark
From
Philippines Diabetes Care Devices Market Report and Forecast 2024-2032 - Product Thumbnail Image

Philippines Diabetes Care Devices Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 160 Pages
  • Philippines
From
Loading Indicator